For the Second Time, Xenco Medical Is Named One of the World’s Most Innovative Companies by Fast Company Magazine

Pioneering medical technology company Xenco Medical has once again been named one of the World’s Most Innovative Companies by Fast Company Magazine. The esteemed annual list recognizes renowned companies whose groundbreaking technologies are ushering in transformative change. Xenco Medical was previously named one of the World’s Most Innovative Companies by Fast Company in 2023. As the recipient of the honor once again in 2025, Xenco Medical joins a rare group of transformational companies named to the highly acclaimed list more than once. Chosen from the globe’s most technologically consequential companies, selection to the list is widely recognized as the preeminent honor a company can receive for its innovations. A trailblazer in its application of materials science to surgical implant and instrument design, Xenco Medical’s breakthrough portfolio of biomimetic implants, regenerative biomaterials, and composite polymer surgical instruments have been amplified in impact by groundbreaking software technologies from post-surgical remote therapeutic monitoring to preoperative holographic surgical simulation. In a statement from Fast Company Magazine, the publication noted, “This year’s list shines a spotlight on businesses that are shaping industry and culture through their innovations to achieve remarkable milestones in all sectors of the economy.”

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250320679002/en/

Xenco Medical has once again been named one of the World’s Most Innovative Companies by Fast Company Magazine in its acclaimed 2025 list. Xenco Medical was previously named one of the World’s Most Innovative Companies in 2023.

“We are deeply humbled and enormously grateful to once again be named one of the World’s Most Innovative Companies by Fast Company. We look forward to continuing our unrelenting pursuit of transforming healthcare through interdisciplinary innovation animated by the belief that interventions must work in concert towards longitudinal care,” said Xenco Medical Founder and CEO Jason Haider.

Dissolving the barriers that typify the siloed nature of surgical care, Xenco Medical has used its TrabeculeX Continuum technology to synergistically cascade the bone-forming potential of its regenerative biomaterial with patient-specific physical rehabilitation exercises delivered through an AI-enabled recovery platform. Inspired by the principles of mechanotransduction, Xenco Medical’s breakthrough harmonization of orthobiologics and digital health has created a seamless link that unifies the intraoperative and postoperative phases of a patient’s journey to recovery. Empowering surgeons to remotely monitor each of their patient’s pain scores, rehab adherence, and functional motion progress through AI-powered pose assessments, the TrabeculeX Continuum by Xenco Medical cultivates a continuous partnership between providers and patients implanted with Xenco Medical’s regenerative biomaterial.

A trailblazing leader in the medical device sector, Xenco Medical’s breakthrough technologies have heralded a value-based approach to healthcare. “Our list of the Most Innovative Companies offers both a comprehensive look at innovation today and a playbook for the future,” said Fast Company editor-in-chief Brendan Vaughan. “This year, we recognize companies that are harnessing AI in deep and meaningful ways, brands that are turning customers into superfans by overdelivering for them, and challengers that are introducing bold ideas and vital competition to their industries. At a time when the world is rapidly shifting, these companies are charting the way forward.” The 2025 list of the World’s Most Innovative Companies was announced by Fast Company Magazine on March 18th of this year and will be followed by an awards ceremony and gala at the Javits Center in New York City on June 5th.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250320679002/en/